Functional genomics and DEC-Tec to identify germ cell-specific contraceptives
功能基因组学和 DEC-Tec 鉴定生殖细胞特异性避孕药
基本信息
- 批准号:10164823
- 负责人:
- 金额:$ 121万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcrosomeAdvisory CommitteesAffinityApplications GrantsAreaBindingBioavailableBiochemistryCRISPR/Cas technologyChemistryClinical TrialsContraceptive AgentsContraceptive methodsCountryDNADataDevelopmentDiagnosisEngineeringEnzymesEpididymisEvaluationFemaleFertilityFertilizationFutureGenomic DNAGenomic approachGerm CellsGoalsGrantHealthHealth Care CostsHealthcareIn VitroInfertilityIntegral Membrane ProteinInternationalLeadLibrariesLigandsMedicineMeiosisMissionMolecularMusNational Institute of Child Health and Human DevelopmentOocytesOral ContraceptivesOrganic ChemistryPPP3CC genePPP3R2 genePathway interactionsPharmaceutical PreparationsPharmacologyPlanetsPopulationPopulation GrowthPregnancyProcessProgram DevelopmentProgram Research Project GrantsProteinsPublic HealthReproductive BiologyResearchResearch PersonnelRoleScientistSeriesSerine ProteaseSignaling ProteinSperm MaturationSperm MotilitySpermatogenesisStrategic PlanningTechnologyTestingTestisTranslatingUnited StatesUniversitiesVisionWomanZona Pellucidaabortionbasecell motilitycollegecontraceptive targetdrug discoverydruggable targeteggfollow-upfunctional genomicsin vivoinhibitor/antagonistinnovationmalemale fertilitymembermenmouse genomemultidisciplinarynovelnovel therapeuticspillpre-clinicalprogramsprototypereproductivereproductive tractreversible contraceptiveside effectsmall moleculesperm cellsperm functionunintended pregnancy
项目摘要
SUMMARY OF P01 APPLICATION
The Strategic Plan 2000 of NICHD states that uncontrolled fertility “is one of the most pressing public health
challenges facing the world today,” and in 2014, NICHD identified contraception as one of the three priority
areas in implementing its scientific vision. Unintended pregnancies are a major health problem worldwide, and
in our country, 45% of pregnancies are unintended, 42% of these end in abortion, and the annual healthcare
costs are more than $7 billion. However, there is no oral contraceptive pill for men. Our multidisciplinary groups
at Baylor College of Medicine and Osaka University have joined forces for the intellectual, technical, and
pharmacologic challenge of defining germ cell-specific pathways essential for fertility and developing high-
quality preclinical compounds to target spermatogenesis, sperm maturation, motility, and/or fertilization as
effective non-hormonal contraceptives for men and women. Our Program Project Grant application describes a
new P01 program based on decades of scientific interactions and discoveries of our investigators. The
proposed male fertility-directed and contraceptive-directed studies will use state-of-the-art functional genomics
and drug discovery approaches to reach our goals. We propose three projects that focus on testis-specific,
epididymis-specific, and/or fertilization-specific targets for which optimal small-molecule ligands have yet to be
identified and for which mechanistic data are lacking. The proposal includes an Administrative Core that will
oversee the finances and stimulate scientific and translational advances of our team. Central to the projects
and our team goals of developing novel contraceptives is our DNA-Encoded Chemistry Technology (DEC-Tec)
Core that will 1) screen our candidate contraceptive targets against unique billion-compound libraries, 2)
produce lead compounds and probes for in vitro mechanistic studies and in vivo contraceptive testing in mice,
and 3) identify preclinical candidates for evaluation in clinical trials in men or women. The major innovative
aspects of this P01 proposal are 1) our collective application of CRISPR/Cas9 to expeditiously engineer the
mouse genome to interrogate male fertility pathways, and 2) our application of DEC-Tec to economically and
rapidly identify high-affinity probes and lead compounds to target our reproductive tract-required proteins for
evaluation of function and proof-of-concept contraceptive analysis in vivo. The primary objective of our P01
studies is to have multiple bioavailable, effective, and reversible contraceptives directed at novel reproductive
targets for testing in men or women within five years. This novel research program will support an
internationally-recognized team of scientists with complementary expertise in organic chemistry,
biochemistry, functional genomics, and reproductive biology, and has the potential of a huge
healthcare payoff by identifying key male fertility pathways and creating unique contraceptives for
reversible disruption of essential spermatogenetic, sperm maturation, and fertilization pathways.
p01应用总结
项目成果
期刊论文数量(80)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cyp1a2-knockout increases the systemic exposure of a serotonin and norepinephrine reuptake inhibitor duloxetine in mice.
Cyp1a2 敲除增加了小鼠体内血清素和去甲肾上腺素再摄取抑制剂度洛西汀的全身暴露。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Qin,Xuan;Xie,Cen;Hakenjos,JohnM;Mackenzie,KevinM;Barzi,Mercedes;Nyshadham,Pranavanand;Khalil,SalehM;Bissig,Karl-Dimiter;Gonzalez,FrankJ;Matzuk,MartinM;Li,Feng
- 通讯作者:Li,Feng
KCTD19 and its associated protein ZFP541 are independently essential for meiosis in male mice.
- DOI:10.1371/journal.pgen.1009412
- 发表时间:2021-05
- 期刊:
- 影响因子:4.5
- 作者:Oura S;Koyano T;Kodera C;Horisawa-Takada Y;Matsuyama M;Ishiguro KI;Ikawa M
- 通讯作者:Ikawa M
Engineered CRISPR-Cas9 nuclease with expanded targeting space.
- DOI:10.1126/science.aas9129
- 发表时间:2018-09-21
- 期刊:
- 影响因子:0
- 作者:Nishimasu H;Shi X;Ishiguro S;Gao L;Hirano S;Okazaki S;Noda T;Abudayyeh OO;Gootenberg JS;Mori H;Oura S;Holmes B;Tanaka M;Seki M;Hirano H;Aburatani H;Ishitani R;Ikawa M;Yachie N;Zhang F;Nureki O
- 通讯作者:Nureki O
ARMC12 regulates spatiotemporal mitochondrial dynamics during spermiogenesis and is required for male fertility.
- DOI:10.1073/pnas.2018355118
- 发表时间:2021-02-09
- 期刊:
- 影响因子:11.1
- 作者:Shimada K;Park S;Miyata H;Yu Z;Morohoshi A;Oura S;Matzuk MM;Ikawa M
- 通讯作者:Ikawa M
Proximity-dependent biotin labeling in testicular germ cells identified TESMIN-associated proteins.
睾丸生殖细胞中依赖性依赖性生物素标记鉴定出与TESMIN相关的蛋白。
- DOI:10.1038/s41598-022-26501-7
- 发表时间:2022-12-23
- 期刊:
- 影响因子:4.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN M. MATZUK其他文献
MARTIN M. MATZUK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN M. MATZUK', 18)}}的其他基金
Kinases as Therapeutic Targets for Endometriosis
激酶作为子宫内膜异位症的治疗靶点
- 批准号:
10674987 - 财政年份:2022
- 资助金额:
$ 121万 - 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
- 批准号:
10682061 - 财政年份:2022
- 资助金额:
$ 121万 - 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
- 批准号:
10764639 - 财政年份:2022
- 资助金额:
$ 121万 - 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
- 批准号:
10419647 - 财政年份:2022
- 资助金额:
$ 121万 - 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
- 批准号:
10598585 - 财政年份:2022
- 资助金额:
$ 121万 - 项目类别:
Kinases as Therapeutic Targets for Endometriosis
激酶作为子宫内膜异位症的治疗靶点
- 批准号:
10532966 - 财政年份:2022
- 资助金额:
$ 121万 - 项目类别:
Targeting testis-specific ubiquitin-proteasome pathways for male contraception
针对男性避孕的睾丸特异性泛素蛋白酶体途径
- 批准号:
10018522 - 财政年份:2019
- 资助金额:
$ 121万 - 项目类别:
Targeting sperm-specific proteins during meiosis and sperm morphogenesis
在减数分裂和精子形态发生过程中靶向精子特异性蛋白
- 批准号:
10164826 - 财政年份:2017
- 资助金额:
$ 121万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 121万 - 项目类别:
Standard Grant














{{item.name}}会员




